Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q3 2024 (September 30)3holders −2
0new positions
2sold out
$18.52avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holders were Nomura Holdings Inc. ($45.1M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($1.9M) and Bank of New York Mellon Corp ($259K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $8.0M |
All 13F filers, Q2 2024 → Q3 2024: 716,596 shares bought and 152,991 shares sold, net +563,605 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Nomura Holdings Inc. | 0.35% | Add +520.6% | 854,254 | $45.1M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 1,500,000 | $1.9M |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $259K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.